GSK’s Hibsago becomes the first ASO approved for chronic hepatitis B, offering patients a new treatment approach for sustained viral control.
Sun Pharma’s $355M acquisition of Unloxcyt gains momentum as the therapy earns NCCN Category 2A status for locally advanced skin cancer.
Pharma giants pour billions into Chinese innovation, securing advanced oncology platforms, AI-powered clinical trials, and next-generation drug-delivery technologies.
Fake medicine billing allegations in Lucknow highlight gaps in pharmaceutical distribution, invoice verification, and drug traceability.
Bajaj Healthcare Q2 Results for FY27 show strong growth in revenue and profitability, supported by rising API exports and formulations sales.
India’s pharmaceutical sector is seeing major developments in drug pricing, cancer treatment, manufacturing, and international market expansion. The Centre has notified a 30 percent trade-margin cap on 137 anti-cancer drugs, while Lupin has...
Neovii Biotech and VINS Bioproducts plan immunoglobulin collaboration with technology transfer to India, potentially strengthening domestic biologics manufacturing and transplant care.
Eli Lilly's Foundayo pill gains EU regulatory backing, highlighting its flexible dosing without food or water restrictions.
.jpeg "Can India's Drug Discovery Push Help Startups Bridge R&D Funding Gap?")
India’s Rs 50 crore drug discovery funding under the PRIP scheme targets startups and MSMEs developing indigenous medicines. Applications close on 10 November 2026.
Mankind Pharma's Rs 511 crore investment in Armed Cell Therapeutics targets next-generation CAR-T therapies for difficult-to-treat cancers.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
